rawfin.tv
Viking Global Discloses 18.8% Stake in Adaptive Biotechnologies
MarketsstocksAI Generated

Viking Global Discloses 18.8% Stake in Adaptive Biotechnologies

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Viking Global entities have filed an amended Schedule 13G/A, disclosing that various Viking firms collectively hold an 18.8% stake in Adaptive Biotechnologies (ADPT). This filing updates their significant institutional ownership in the biotech company.

ADPTBiotechnologyInstitutional OwnershipSEC Filing

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks